Article Versions Notes

Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreiros A, Abalo A, López Gil C, Oltra SS, de Santiago J, Cabrera S, et al. Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer. Journal of Clinical Medicine. 2020; 9(2):585. https://doi.org/10.3390/jcm9020585

Casas-Arozamena, Carlos, Eva Díaz, Cristian Pablo Moiola, Lorena Alonso-Alconada, Alba Ferreiros, Alicia Abalo, Carlos López Gil, Sara S. Oltra, Javier de Santiago, Silvia Cabrera, and et al. 2020. "Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer" Journal of Clinical Medicine 9, no. 2: 585. https://doi.org/10.3390/jcm9020585

Casas-Arozamena, C., Díaz, E., Moiola, C. P., Alonso-Alconada, L., Ferreiros, A., Abalo, A., López Gil, C., Oltra, S. S., de Santiago, J., Cabrera, S., Sampayo, V., Bouso, M., Arias, E., Cueva, J., Colas, E., Vilar, A., Gil-Moreno, A., Abal, M., Moreno-Bueno, G., & Muinelo-Romay, L. (2020). Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer. Journal of Clinical Medicine, 9(2), 585. https://doi.org/10.3390/jcm9020585